ID PRPS2_HUMAN Reviewed; 318 AA. AC P11908; Q0VDH9; Q0VDI0; Q15245; Q2TAK7; DT 01-OCT-1989, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 27-MAR-2024, entry version 230. DE RecName: Full=Ribose-phosphate pyrophosphokinase 2; DE EC=2.7.6.1; DE AltName: Full=PPRibP; DE AltName: Full=Phosphoribosyl pyrophosphate synthase II; DE Short=PRS-II; GN Name=PRPS2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Testis; RX PubMed=2538352; DOI=10.1016/0014-5793(89)81159-7; RA Iizasa T., Taira M., Shimada H., Ishijima S., Tatibana M.; RT "Molecular cloning and sequencing of human cDNA for phosphoribosyl RT pyrophosphate synthetase subunit II."; RL FEBS Lett. 244:47-50(1989). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Testis; RX PubMed=2560337; DOI=10.1007/978-1-4684-5673-8_84; RA Iizasa T., Taira M., Shimada H., Tatibana M.; RT "Deduced amino acid sequence from human phosphoribosylpyrophosphate RT synthetase subunit II cDNA."; RL Adv. Exp. Med. Biol. 253A:519-523(1989). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Testis, and Uterus; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-40. RC TISSUE=Leukocyte; RX PubMed=1314091; DOI=10.1016/0167-4781(92)90521-z; RA Ishizuka T., Iizasa T., Taira M., Ishijima S., Sonoda T., Shimada H., RA Nagatake N., Tatibana M.; RT "Promoter regions of the human X-linked housekeeping genes PRPS1 and PRPS2 RT encoding phosphoribosylpyrophosphate synthetase subunit I and II RT isoforms."; RL Biochim. Biophys. Acta 1130:139-148(1992). RN [5] RP PROTEIN SEQUENCE OF 2-29; 34-49; 85-96; 164-196; 205-214; 244-282 AND RP 287-318, CLEAVAGE OF INITIATOR METHIONINE, AND IDENTIFICATION BY MASS RP SPECTROMETRY. RC TISSUE=Cervix carcinoma, Mammary carcinoma, and Osteosarcoma; RA Bienvenut W.V., Calvo F., Bensaad K., Vousden K.H., Matallanas D., RA Cooper W.N., Kolch W., Lourenco F., Olson M.F.; RL Submitted (DEC-2009) to UniProtKB. RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). CC -!- FUNCTION: Catalyzes the synthesis of phosphoribosylpyrophosphate (PRPP) CC that is essential for nucleotide synthesis. CC -!- CATALYTIC ACTIVITY: CC Reaction=ATP + D-ribose 5-phosphate = 5-phospho-alpha-D-ribose 1- CC diphosphate + AMP + H(+); Xref=Rhea:RHEA:15609, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:30616, ChEBI:CHEBI:58017, ChEBI:CHEBI:78346, CC ChEBI:CHEBI:456215; EC=2.7.6.1; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC -!- ACTIVITY REGULATION: Activated by magnesium and inorganic phosphate. CC Competitively or non-competitively inhibited by ADP, 2,3- CC bisphosphoglyceride or GDP. CC -!- PATHWAY: Metabolic intermediate biosynthesis; 5-phospho-alpha-D-ribose CC 1-diphosphate biosynthesis; 5-phospho-alpha-D-ribose 1-diphosphate from CC D-ribose 5-phosphate (route I): step 1/1. CC -!- SUBUNIT: Homodimer. The active form is probably a hexamer composed of 3 CC homodimers (By similarity). {ECO:0000250}. CC -!- INTERACTION: CC P11908; P28799: GRN; NbExp=3; IntAct=EBI-4290895, EBI-747754; CC P11908; P04792: HSPB1; NbExp=3; IntAct=EBI-4290895, EBI-352682; CC P11908; O60333-2: KIF1B; NbExp=3; IntAct=EBI-4290895, EBI-10975473; CC P11908; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-4290895, EBI-945833; CC P11908; Q96HA8: NTAQ1; NbExp=4; IntAct=EBI-4290895, EBI-741158; CC P11908; P60891: PRPS1; NbExp=10; IntAct=EBI-4290895, EBI-749195; CC P11908; P11908: PRPS2; NbExp=4; IntAct=EBI-4290895, EBI-4290895; CC P11908; Q14558: PRPSAP1; NbExp=5; IntAct=EBI-4290895, EBI-724449; CC P11908; Q9Y3C5: RNF11; NbExp=3; IntAct=EBI-4290895, EBI-396669; CC P11908; P02766: TTR; NbExp=3; IntAct=EBI-4290895, EBI-711909; CC P11908; O76024: WFS1; NbExp=3; IntAct=EBI-4290895, EBI-720609; CC P11908-2; P60891: PRPS1; NbExp=4; IntAct=EBI-12063547, EBI-749195; CC P11908-2; Q14558: PRPSAP1; NbExp=3; IntAct=EBI-12063547, EBI-724449; CC P11908-2; O60256: PRPSAP2; NbExp=4; IntAct=EBI-12063547, EBI-724960; CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P11908-1; Sequence=Displayed; CC Name=2; CC IsoId=P11908-2; Sequence=VSP_027769; CC -!- SIMILARITY: Belongs to the ribose-phosphate pyrophosphokinase family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH30019.2; Type=Erroneous initiation; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; Y00971; CAA68785.1; -; mRNA. DR EMBL; BC030019; AAH30019.2; ALT_INIT; mRNA. DR EMBL; BC040483; AAH40483.3; -; mRNA. DR EMBL; BC110875; AAI10876.2; -; mRNA. DR EMBL; BC119662; AAI19663.1; -; mRNA. DR EMBL; BC119663; AAI19664.1; -; mRNA. DR EMBL; D28134; BAA05676.1; -; Genomic_DNA. DR CCDS; CCDS14150.1; -. [P11908-1] DR CCDS; CCDS43918.1; -. [P11908-2] DR PIR; S02778; KIHUR2. DR RefSeq; NP_001034180.1; NM_001039091.2. [P11908-2] DR RefSeq; NP_002756.1; NM_002765.4. [P11908-1] DR PDB; 7YK1; EM; 3.08 A; A/B/C/D/E/F=1-318. DR PDBsum; 7YK1; -. DR AlphaFoldDB; P11908; -. DR EMDB; EMD-33883; -. DR SMR; P11908; -. DR BioGRID; 111617; 236. DR IntAct; P11908; 51. DR MINT; P11908; -. DR STRING; 9606.ENSP00000381504; -. DR GlyGen; P11908; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P11908; -. DR MetOSite; P11908; -. DR PhosphoSitePlus; P11908; -. DR SwissPalm; P11908; -. DR BioMuta; PRPS2; -. DR DMDM; 125583; -. DR REPRODUCTION-2DPAGE; IPI00219617; -. DR REPRODUCTION-2DPAGE; P11908; -. DR EPD; P11908; -. DR jPOST; P11908; -. DR MassIVE; P11908; -. DR MaxQB; P11908; -. DR PaxDb; 9606-ENSP00000381504; -. DR PeptideAtlas; P11908; -. DR ProteomicsDB; 52809; -. [P11908-1] DR ProteomicsDB; 52810; -. [P11908-2] DR Pumba; P11908; -. DR Antibodypedia; 8471; 265 antibodies from 29 providers. DR DNASU; 5634; -. DR Ensembl; ENST00000380668.10; ENSP00000370043.5; ENSG00000101911.13. [P11908-1] DR Ensembl; ENST00000398491.6; ENSP00000381504.2; ENSG00000101911.13. [P11908-2] DR GeneID; 5634; -. DR KEGG; hsa:5634; -. DR MANE-Select; ENST00000380668.10; ENSP00000370043.5; NM_002765.5; NP_002756.1. DR UCSC; uc004cva.4; human. [P11908-1] DR AGR; HGNC:9465; -. DR CTD; 5634; -. DR DisGeNET; 5634; -. DR GeneCards; PRPS2; -. DR HGNC; HGNC:9465; PRPS2. DR HPA; ENSG00000101911; Tissue enhanced (ovary, parathyroid gland). DR MIM; 311860; gene. DR neXtProt; NX_P11908; -. DR OpenTargets; ENSG00000101911; -. DR PharmGKB; PA33820; -. DR VEuPathDB; HostDB:ENSG00000101911; -. DR eggNOG; KOG1448; Eukaryota. DR GeneTree; ENSGT00950000182803; -. DR HOGENOM; CLU_033546_4_0_1; -. DR InParanoid; P11908; -. DR OMA; AHEFARY; -. DR OrthoDB; 276387at2759; -. DR PhylomeDB; P11908; -. DR TreeFam; TF106366; -. DR BioCyc; MetaCyc:HS02317-MONOMER; -. DR PathwayCommons; P11908; -. DR Reactome; R-HSA-73843; 5-Phosphoribose 1-diphosphate biosynthesis. DR SignaLink; P11908; -. DR SIGNOR; P11908; -. DR UniPathway; UPA00087; UER00172. DR BioGRID-ORCS; 5634; 22 hits in 779 CRISPR screens. DR ChiTaRS; PRPS2; human. DR GenomeRNAi; 5634; -. DR Pharos; P11908; Tbio. DR PRO; PR:P11908; -. DR Proteomes; UP000005640; Chromosome X. DR RNAct; P11908; Protein. DR Bgee; ENSG00000101911; Expressed in seminal vesicle and 201 other cell types or tissues. DR ExpressionAtlas; P11908; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0005829; C:cytosol; IEA:Ensembl. DR GO; GO:0002189; C:ribose phosphate diphosphokinase complex; IBA:GO_Central. DR GO; GO:0005524; F:ATP binding; ISS:UniProtKB. DR GO; GO:0042802; F:identical protein binding; IPI:IntAct. DR GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW. DR GO; GO:0000287; F:magnesium ion binding; IEA:InterPro. DR GO; GO:0042803; F:protein homodimerization activity; ISS:UniProtKB. DR GO; GO:0004749; F:ribose phosphate diphosphokinase activity; ISS:UniProtKB. DR GO; GO:0006015; P:5-phosphoribose 1-diphosphate biosynthetic process; IBA:GO_Central. DR GO; GO:0006139; P:nucleobase-containing compound metabolic process; TAS:ProtInc. DR GO; GO:0006098; P:pentose-phosphate shunt; IEA:Ensembl. DR GO; GO:0016310; P:phosphorylation; IEA:UniProtKB-KW. DR GO; GO:0006164; P:purine nucleotide biosynthetic process; IBA:GO_Central. DR GO; GO:0009156; P:ribonucleoside monophosphate biosynthetic process; IEA:InterPro. DR CDD; cd06223; PRTases_typeI; 1. DR Gene3D; 3.40.50.2020; -; 2. DR HAMAP; MF_00583_B; RibP_PPkinase_B; 1. DR InterPro; IPR000842; PRib_PP_synth_CS. DR InterPro; IPR029099; Pribosyltran_N. DR InterPro; IPR000836; PRibTrfase_dom. DR InterPro; IPR029057; PRTase-like. DR InterPro; IPR005946; Rib-P_diPkinase. DR InterPro; IPR037515; Rib-P_diPkinase_bac. DR NCBIfam; TIGR01251; ribP_PPkin; 1. DR PANTHER; PTHR10210; RIBOSE-PHOSPHATE DIPHOSPHOKINASE FAMILY MEMBER; 1. DR PANTHER; PTHR10210:SF110; RIBOSE-PHOSPHATE PYROPHOSPHOKINASE 2; 1. DR Pfam; PF14572; Pribosyl_synth; 1. DR Pfam; PF13793; Pribosyltran_N; 1. DR SMART; SM01400; Pribosyltran_N; 1. DR SUPFAM; SSF53271; PRTase-like; 1. DR PROSITE; PS00114; PRPP_SYNTHASE; 1. DR Genevisible; P11908; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; ATP-binding; Direct protein sequencing; KW Kinase; Magnesium; Metal-binding; Nucleotide biosynthesis; KW Nucleotide-binding; Reference proteome; Transferase. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|Ref.5" FT CHAIN 2..318 FT /note="Ribose-phosphate pyrophosphokinase 2" FT /id="PRO_0000141074" FT REGION 212..227 FT /note="Binding of phosphoribosylpyrophosphate" FT /evidence="ECO:0000255" FT BINDING 96..101 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 128 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255" FT BINDING 130 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000250" FT BINDING 130 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255" FT BINDING 139 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255" FT BINDING 143 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT /evidence="ECO:0000255" FT VAR_SEQ 102 FT /note="K -> KVGE (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_027769" FT STRAND 4..8 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 13..23 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 30..34 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 40..44 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 52..56 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 63..79 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 83..91 FT /evidence="ECO:0007829|PDB:7YK1" FT TURN 93..96 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 102..104 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 108..119 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 123..128 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 132..137 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 142..145 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 148..158 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 162..164 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 166..168 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 170..172 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 175..183 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 191..193 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 206..209 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 216..219 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 221..225 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 228..238 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 244..247 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 249..251 FT /evidence="ECO:0007829|PDB:7YK1" FT TURN 255..257 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 258..262 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 266..272 FT /evidence="ECO:0007829|PDB:7YK1" FT TURN 278..282 FT /evidence="ECO:0007829|PDB:7YK1" FT STRAND 287..290 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 293..305 FT /evidence="ECO:0007829|PDB:7YK1" FT HELIX 309..314 FT /evidence="ECO:0007829|PDB:7YK1" SQ SEQUENCE 318 AA; 34769 MW; 72A2873408250C31 CRC64; MPNIVLFSGS SHQDLSQRVA DRLGLELGKV VTKKFSNQET SVEIGESVRG EDVYIIQSGC GEINDNLMEL LIMINACKIA SSSRVTAVIP CFPYARQDKK DKSRAPISAK LVANMLSVAG ADHIITMDLH ASQIQGFFDI PVDNLYAEPA VLQWIRENIA EWKNCIIVSP DAGGAKRVTS IADRLNVEFA LIHKERKKAN EVDRMVLVGD VKDRVAILVD DMADTCGTIC HAADKLLSAG ATKVYAILTH GIFSGPAISR INNAAFEAVV VTNTIPQEDK MKHCTKIQVI DISMILAEAI RRTHNGESVS YLFSHVPL //